» Articles » PMID: 17309106

Proteomic and Functional Alterations in Brain Mitochondria from Tg2576 Mice Occur Before Amyloid Plaque Deposition

Overview
Journal Proteomics
Date 2007 Feb 20
PMID 17309106
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Synaptic dysfunction is an early event in Alzheimer's disease patients and has also been detected in transgenic mouse models. In the present study, we analyzed proteomic changes in synaptosomal fractions from Tg2576 mice that overexpress mutant human amyloid precursor protein (K670N, M671L) and from their nontransgenic littermates. Cortical and hippocampal tissue was microdissected at the onset of cognitive impairment, but before deposition of amyloid plaques. Crude synaptosomal fractions were prepared by differential centrifugation, proteins were separated by 2-D DIGE and identified by MS/MS. Significant alterations were detected in mitochondrial heat shock protein 70 pointing to a mitochondrial stress response. Subsequently, synaptosomal versus nonsynaptic mitochondria were purified from Tg2576 mice brains by density gradient centrifugation. Mitochondrial proteins were separated by IEF or Blue-native gel electrophoresis in the first dimension and SDS-PAGE in the second dimension. Numerous changes in the protein subunit composition of the respiratory chain complexes I and III were identified. Levels of corresponding mRNAs remain unchanged as shown by Affymetrix oligonucleotide array analysis. Functional examination revealed impaired state 3 respiration and uncoupled respiration in brain mitochondria from young Tg2576 mice. By immunoblotting, amyloid-beta oligomers were detected in synaptosomal fractions from Tg2576 mice and reduced glucose metabolism was observed in Tg2576 mice brains by [14C]-2-deoxyglucose infusion. Taken together, we demonstrate alterations in the mitochondrial proteome and function that occur in Tg2576 mice brains before amyloid plaque deposition suggesting that mitochondria are early targets of amyloid-beta aggregates.

Citing Articles

Pathology and Treatments of Alzheimer's Disease Based on Considering Changes in Brain Energy Metabolism Due to Type 2 Diabetes.

Yanai H, Adachi H, Hakoshima M, Katsuyama H Molecules. 2025; 29(24.

PMID: 39770025 PMC: 11677283. DOI: 10.3390/molecules29245936.


Prodromic Inflammatory-Oxidative Stress in Peritoneal Leukocytes of Triple-Transgenic Mice for Alzheimer's Disease.

Ceprian N, Martinez de Toda I, Mate I, Garrido A, Gimenez-Llort L, De la Fuente M Int J Mol Sci. 2024; 25(13).

PMID: 39000092 PMC: 11241217. DOI: 10.3390/ijms25136976.


Effects of Redox Homeostasis and Mitochondrial Damage on Alzheimer's Disease.

Wu Y, Hsieh H Antioxidants (Basel). 2023; 12(10).

PMID: 37891895 PMC: 10604635. DOI: 10.3390/antiox12101816.


Transcriptomic Analysis in the Hippocampus and Retina of Tg2576 AD Mice Reveals Defective Mitochondrial Oxidative Phosphorylation and Recovery by Tau 12A12mAb Treatment.

Morello G, Guarnaccia M, La Cognata V, Latina V, Calissano P, Amadoro G Cells. 2023; 12(18).

PMID: 37759477 PMC: 10527038. DOI: 10.3390/cells12182254.


Rat Group IIA Secreted Phospholipase A Binds to Cytochrome c Oxidase and Inhibits Its Activity: A Possible Episode in the Development of Alzheimer's Disease.

Ivanusec A, Sribar J, Leonardi A, Zorovic M, Zivin M, Krizaj I Int J Mol Sci. 2022; 23(20).

PMID: 36293221 PMC: 9604285. DOI: 10.3390/ijms232012368.